TransMed7

Accuracy - the Crucial Factor

Accuracy — with Precision, Control, Effortless Penetration, Capture, Transport — the hummingbird is nature’s most skillful surgeon. TransMed7’s Zero5 technology leverages these principles to unlock the power of repeatable access to every area of the body to remove, reveal, deliver or replace. Enter the new frontier.  

Zero5

SpeedBird

Concorde

Cardinal

ABOUT

Who We Are
And What We Do

TransMed7 is a privately-held medical technology company founded in 2010 to generate transformational technologies for diverse fields of healthcare around the world.

We are focused on the highly efficient development of innovative, cost effective, minimally invasive medical devices via several project companies with a particular focus in oncologic, regenerative, and cardiovascular disease.

Our products are designed to address critical healthcare needs in medical fields such as: breast health; soft tissue surgery, including small or fragile tissues and difficult to access areas; endoscopy, laparoscopy, robotics applications; bone marrow biopsy and harvest; interventional cardiology; and minimally invasive peripheral vascular procedures.

News & Announcements

TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its Concorde US<br>(Ultrasound) and Concorde ST (Stereotactic) Soft Tissue Biopsy Device Platform

TransMed7, LLC Announces 510(k) Clearance by the U.S. FDA for its Concorde US
(Ultrasound) and Concorde ST (Stereotactic) Soft Tissue Biopsy Device Platform

Portola Valley, CA –TransMed7, LLC announced today that the United States Food and Drug Administration (FDA) has cleared…
Pre-Production Test Devices of Heron’s “Zero5” Work Element Scaled to 18 Gauge and on Long (16 cm+) Needles Being Prepared

Pre-Production Test Devices of Heron’s “Zero5” Work Element Scaled to 18 Gauge and on Long (16 cm+) Needles Being Prepared

TransMed7 is delighted to announce the ongoing production of prototype HeronTM devices for its newly announced Project Company,…
TransMed7 Continues to Strengthen its Intellectual Property Position

TransMed7 Continues to Strengthen its Intellectual Property Position

TransMed7’s Intellectual Property portfolio is built on a robust patent generation and protection strategy, developed and backed by…
Prototypes for Cardinal, a Fine Needle Core Biopsy Device and VacuPac, a Portable External Vacuum Assist Device Shown at ASBrS

Prototypes for Cardinal, a Fine Needle Core Biopsy Device and VacuPac, a Portable External Vacuum Assist Device Shown at ASBrS

We were delighted to present several prototype CardinalTM devices for the first time at this year’s ASBrS meeting.…

Want to Know More?

For further information on TransMed7 and its platform technologies,
please reach out to us using the form below.
Scroll to Top